Clinical trials
Thyroid Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
121 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 17 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 9 |
| 2022 | 16 |
| 2023 | 8 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 121 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Medical University | 6 |
| Fudan University | 5 |
| Assiut University | 4 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Umraniye Education and Research Hospital | 4 |
| Bo Wang,MD | 3 |
| Hospices Civils de Lyon | 3 |
| Peking Union Medical College Hospital | 3 |
| Seoul National University Hospital | 3 |
| Tel-Aviv Sourasky Medical Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 121 |
| Thyroid Nodule | 15 |
| Thyroid Cancer, Papillary | 10 |
| Breast Neoplasms | 6 |
| Thyroid Diseases | 6 |
| Goiter | 4 |
| Head and Neck Neoplasms | 4 |
| Thyroid Carcinoma, Anaplastic | 4 |
| Adenocarcinoma, Follicular | 3 |
| Carcinoma, Medullary | 3 |
Trials
Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.
21 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.